Key Features
Innovate UK, LifeArc and Medicines Discovery Catapult partnership PACE are offering £10m grant funding and support for early phase drug discovery and diagnostic projects.
Programme: PACE
Award: Share of up to £10 million
Opens: 19th Oct 2023
Closes: 24th Nov 2023
PACE are looking to help create and advance an exciting and diverse pipeline of preclinical phase projects aimed at treating bacterial infections with high unmet need.
With this aim PACE’s first funding call will focus solely on early-stage, novel, antibacterial therapeutics.
Expressions of interest are invited by 24 November, and an informational webinar will be held on 31 October for interested parties.
PACE are looking for projects directed at the highest-burden drug-resistant bacterial infections and indications, as highlighted by the Lancet study and by the WHO priority list. In scope indications are: Lower Respiratory Tract Infections (LRTI); Bloodstream Infections (BSI); Intra-abdominal Infections (IAI); and Urinary Tract Infections (UTI).
And projects should be directed at one or more of the following drug-resistant bacteria. They are as follows:
Projects should be transformational, with the aim to fill a gap for innovative & differentiated antimicrobials in the clinical pipeline. We encourage projects that are based on the concept of precision medicine where consideration is given to potential patient stratification and diagnostics requirements. Our criteria are aligned with those of potential follow-on funders and the NICE subscription model criteria, paving a route from the bench to patient impact.
PACE’s funding is open to researchers in academia and small and medium enterprises (SMEs) worldwide, including consortia (Large Pharma partners permitted, but must cover own costs)
Applications should have a single lead applicant, however co-applicants are welcome.
PACE intend to fund projects looking at:
Up to 12 applicants will be awarded a maximum of £1 million in grant funding, with projects expected to last up to two years. AMR innovators worldwide are eligible to apply.
Book an appointment to speak to one of our advisors to discuss your eligibility to apply for this Grant Funding opportunity.